Abstract:Objective: By introducing the pilot situation of post-market supervision of medical devices purchased by third-party institutions in Jiangsu Province, China, the problems exposed by them were analyzed. At the same time, it draws on relevant advanced experience in the management of EU notified bodies to provide suggestions for optimizing China's follow-up practices and promoting social co-governance supervision. Method: Conduct on-the-spot investigations in Jiangsu Provincial Food and Drug Administration, China, conduct interviews with regulators on the progress of the project, and conduct in-depth communication. A large number of inquiries about the relevant research literature of the EU notified body and the laws and regulations promulgated by the EU, and systematic analysis. Results: In the introduction of third-party agencies to assist post-market supervision of medical devices, the Chinese government still has problems such as lack of relevant laws and regulations, imperfect access mechanisms for third-party agencies, imperfect supervision mechanisms, and backward regulatory informatization construction. Conclusion: Introducing third-party agencies to assist in the supervision of medical devices can effectively ease the pressure on supervision and supplement supervision resources. It is suggested that the Chinese government learn from the management experience of the EU notified bodies, improve the regulatory legal system, introduce relevant regulations, improve the access mechanism of third-party institutions, improve the supervision mechanism, strengthen the construction of supervision informatization, and build a unified supervision platform.

The Enlightenment of the Management of EU Notified Bodies to China's Introduction of Third-Party Institutions for Medical Device Supervision

[Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A]

Supervision System of AI-based Software As a Medical Device

Analysis and Reflection on the Current Situation of National Medical Device Supervision and Inspection

Implication on Global Medical Device's Post-Market Surveillance for China

The Comparison and References of the Medical Device Manufacturers' Supervision and Management Between the USA and China

Experience of Major Medical Equipment Management of Foreign Countries and its Significance for China

[Simple Suggestion of Adapting Requirements of Medical Devices New Supervision Regulation System for Medical Device Manufacturers].

Comparative Study on Monitoring System of Medical Device Adverse Events in America, European Union and China

The Third-Party Regulation on Food Safety in China: A Review

[Analysis and Suggestions on Status Quo of Commissioned Production under Medical Device Marketing Authorization Holder System in China].

A Study On The Function Of Medical Device Postmarket Monitoring Technical System In China

The Current Problems of Regulation of Medical Devices and Countermeasures

Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China

Advancing medical device regulatory reforms for innovation, translation and industry development in China

Analysis on the registration and review system of emergency medical devices in China and abroad in the context of COVID-19

Scientific Medical Supervision in the Perspective of Off-label Uses

Comparison and Analysis of the Health Products Supervisions in China,Japan,USA and EU

Analyses about the Optimizing Approach of Supervising Medical Device Market Institution

Control, Coordination, and Capacity: Deficits in China’s Frontline Regulatory System for Food Safety

[Study on the reform and improvement of the medical device registration system in China].